Article · 29 Dec 2025
Conference abstractPublished 27 Oct 2014
Challenges faced in the development of biosimilars
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Biosimilars are biological products manufactured after expiry of the patent of innovator biopharmaceuticals. As the patents of a growing number of biologic medicines are due to expire, there is an increased interest in the development of biosimilars. The manufacturing process of biosimilars is complex and more challenging. It is a multistep process that starts with a unique cell line and takes many proprietary steps to ensure that the final product has the target protein and minimal to no impurities. Even minor changes in substrate and manufacturing process can cause significant changes and may affect patient safety and clinical efficacy of the product. For efficacy concern, high quality bioanalytical methods are required to assess the biological activity, physicochemical integrity and stability of biosimilars. The important safety concern is immunogenicity. Sensitivity and specificity of assays for testing immunogenic responses may be insufficient to predict rare cases of immunogenicity due to lack of standardization and validation of methods to measure anti-drug antibodies. The quality, efficacy and safety comparison between biosimilars and innovator product is crucial and must be performed in a step wise manner to demonstrate biosimilarity.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Bioanalysis & Biomedicine.
Article · 29 Dec 2025
Epigenetic Modifications: Bioanalysis for Disease and Therapeutics
Article · 29 Dec 2025
Advancing Bioanalysis: New Tech, AI, and Precision Medicine
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioanalysis & Biomedicine
- BylineArticles whose byline prints “Hima Bindu Gujjarlamudi”

